LLY vs ORMP
Eli Lilly and Company (LLY) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LLY and ORMP stock pages for the full models.
Not investment advice.